Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 08-Oct-24 4:44 PM View:  | X4 Pharmaceuticals, Inc (XFOR) | 07-Oct-24 | Sale (Planned) | 230,645 | $0.55 | $126,901.00 | (100%) 230.65K to 0 | |
| 08-Oct-24 4:44 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 04-Oct-24 | Grant | 230,645 | -- | -- | 100% 0 to 230.65K | |
| 11-Mar-24 5:19 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Mar-24 | Sale | 52,500 | $0.88 | $46,347.00 | (100%) 52.5K to 0 | |
| 12-Feb-24 5:03 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 12-Feb-24 | Sale (Planned) | 27,721 | $1.01 | $27,973.30 | (35%) 80.22K to 52.5K | |
| 03-Nov-23 4:42 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Nov-23 | Sale (Planned) | 230,645 | $0.73 | $168,371.00 | (74%) 310.87K to 80.22K | |
| 02-Nov-23 5:04 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 31-Oct-23 | Grant | 230,645 | -- | -- | 288% 80.22K to 310.87K | |
| 05-Jul-23 4:04 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-23 | Market Sale (Planned) | 2,641 | $1.89 | $4,991.49 | (3%) 82.86K to 80.22K | (12%) |
| 26-Jun-23 4:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-23 | Market Sale (Planned) | 5,417 | $1.93 | $10,454.80 | (6%) 88.28K to 82.86K | (10%) |
| 16-Jun-23 4:17 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jun-23 | Market Sale | 5,417 | $2.22 | $12,025.70 | (6%) 93.7K to 88.28K | 5% |
| 13-Mar-23 4:50 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 10-Mar-23 | Sale | 52,500 | $0.84 | $44,100.00 | (36%) 146.2K to 93.7K | |
| 15-Feb-23 5:12 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 13-Feb-23 | Sale | 27,721 | $0.93 | $25,780.50 | (16%) 173.92K to 146.2K | |
| 19-Aug-22 1:04 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-22 | Sale (Planned) | 10,834 | -- | -- | (6%) 184.75K to 173.92K | |
| 01-Jul-22 5:01 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-22 | Sale (Planned) | 2,641 | -- | -- | (1%) 187.39K to 184.75K | |
| 27-Jun-22 4:14 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Jun-22 | Sale | 5,416 | -- | -- | (3%) 192.81K to 187.39K | |
| 17-Jun-22 4:22 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 16-Jun-22 | Sale (Planned) | 5,416 | -- | -- | (3%) 198.22K to 192.81K | |
| 01-Mar-22 4:09 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 01-Mar-22 | Grant | 105,000 | -- | -- | 113% 93.22K to 198.22K | |
| 14-Feb-22 10:00 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 11-Feb-22 | Sale (Planned) | 27,721 | -- | -- | (23%) 120.94K to 93.22K | |
| 19-Aug-21 4:26 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-21 | Market Sale (Planned) | 10,832 | $5.10 | $55,243.20 | (8%) 131.78K to 120.94K | 4% |
| 01-Jul-21 8:18 AM View: | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-21 | Market Sale (Planned) | 2,641 | $6.64 | $17,536.20 | (2%) 134.42K to 131.78K | 2% |
| 25-Jun-21 4:03 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Jun-21 | Market Sale (Planned) | 5,417 | $7.01 | $37,973.20 | (4%) 139.84K to 134.42K | |
| 25-Jun-21 4:03 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 23-Jun-21 | Grant | 16,250 | -- | -- | 13% 123.58K to 139.84K | |
| 17-Jun-21 5:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jun-21 | Grant | 16,250 | -- | -- | 14% 112.75K to 129.0K | |
| 17-Jun-21 5:13 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 15-Jun-21 | Market Sale (Planned) | 5,417 | $7.84 | $42,469.30 | (4%) 129.0K to 123.58K | |
| 25-Mar-21 5:09 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 24-Mar-21 | Grant | 83,163 | -- | -- | 281% 29.59K to 112.75K | |
| 22-Sep-20 4:11 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 21-Sep-20 | Market Sale (Planned) | 10,834 | $7.08 | $76,704.70 | (27%) 40.42K to 29.59K | 9% |
| 18-Aug-20 8:16 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Aug-20 | Grant | 16,250 | -- | -- | 67% 24.17K to 40.42K | |
| 18-Aug-20 8:16 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 14-Aug-20 | Grant | 16,250 | -- | -- | 205% 7.92K to 24.17K | |
| 01-Jul-20 4:10 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-20 | Payment of Exercise | 916 | $9.32 | $8,537.12 | (9%) 10.56K to 9.65K | 31% |
| 01-Jul-20 4:10 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 30-Jun-20 | Market Sale (Planned) | 1,725 | $9.04 | $15,594.00 | (18%) 9.65K to 7.92K | 29% |
| 19-Jun-19 4:16 PM View: | X4 Pharmaceuticals, Inc (XFOR) | 17-Jun-19 | Grant | 10,564 | -- | -- | 100% 0 to 10.56K |